Roychoudhury P, Feelixge HSDe Silva, Pietz HL, Stone D, Jerome KR, Schiffer JT.  2016.  Pharmacodynamics of anti-HIV gene therapy using viral vectors and targeted endonucleases.. J Antimicrob Chemother. 71(8):2089-99.

Hoban MD, Cost GJ, Mendel MC, Romero Z, Kaufman ML, Joglekar AV, Ho M, Lumaquin D, Gray D, Lill GR et al..  2015.  Correction of the sickle cell disease mutation in human hematopoietic stem/progenitor cells.. Blood. 125(17):2597-604.

Kitchen SG, Levin BR, Bristol G, Rezek V, Kim S, Aguilera-Sandoval C, Balamurugan A, Yang OO, Zack JA.  2012.  In vivo suppression of HIV by antigen specific T cells derived from engineered hematopoietic stem cells.. PLoS Pathog. 8(4):e1002649.

Vatakis DN, Bristol GC, Kim SG, Levin B, Liu W, Radu CG, Kitchen SG, Zack JA.  2012.  Using the BLT humanized mouse as a stem cell based gene therapy tumor model.. J Vis Exp. (70):e4181.

Ding H, Wang R, Marcel R, Fisher DZ.  2001.  Adenovirus-mediated expression of a truncated PDGFbeta receptor inhibits thrombosis and neointima formation in an avian arterial injury model.. Thromb Haemost. 86(3):914-22.